SCHEMBL6168575

SCHEMBL6168575

O=C1Nc2cc(Cl)ccc2C(c2ccccc2)N1C1CCN(Cc2ccccc2)CC1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRM3 P20309 7/20 0.50
CHRM2 P08172 6/20 0.50
CHRM1 P11229 1/20 0.48
OPRL1 P41146 2/20 0.47
DRD2 P14416 3/20 0.47
DRD4 P21917 3/20 0.47
DRD3 P35462 2/20 0.47
OPRM1 P35372 2/20 0.47
MEN1 O00255 1/20 0.46
KMT2A Q03164 1/20 0.46
SIGMAR1 Q99720 1/20 0.46
KDM4E B2RXH2 1/20 0.46
ALDH1A1 P00352 1/20 0.46
GLA P06280 1/20 0.46
GAA P10253 1/20 0.46
MAPT P10636 1/20 0.46
HTT P42858 1/20 0.46
ATM Q13315 1/20 0.46
L3MBTL1 Q9Y468 1/20 0.46
OPRK1 P41145 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL6166573 0.99 CHRM3 (0.49) CHRM3CHRM2CHRM1OPRL1DRD2
SCHEMBL8567873 0.91 MEN1 (0.49) CHRM3CHRM2CHRM1OPRL1DRD2
SCHEMBL6170271 0.91 CHRM2 (0.45) CHRM3CHRM2CHRM1OPRL1DRD2
SCHEMBL8564439 0.91 CHRM2 (0.55) CHRM3CHRM2OPRL1DRD2DRD4
SCHEMBL6166884 0.89 CHRM3 (0.51) CHRM3CHRM2CHRM1OPRL1DRD2
SCHEMBL6168165 0.88 CHRM3 (0.49) CHRM3CHRM2OPRL1DRD2DRD4
SCHEMBL8569508 0.88 MEN1 (0.53) CHRM3CHRM2OPRL1DRD2DRD4
SCHEMBL6168606 0.88 OPRL1 (0.52) CHRM3CHRM2OPRL1DRD2DRD4
SCHEMBL29445321 0.88 OPRL1 (0.52) CHRM3CHRM2OPRL1DRD2DRD4
SCHEMBL6169683 0.84 MEN1 (0.48) CHRM3CHRM2CHRM1DRD2DRD4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1122253-B1 QUINAZOLINONE DERIVATIVES SUMITOMO PHARMA (JP) 2005-08-17 EP disclosed
US-6645971-B1 Pollakiuria and urinary incontinence treatment; muscarinic receptor antagonists; anticholinergic, anticonvulsants, antiulcer, and antiasthmatics; Parkinson*s disease SUMITOMO PHARMACEUTICALS COMPANY LIMITED (JP) 2003-11-11 US disclosed
EP-1122253-A1 QUINAZOLINONE DERIVATIVES SUMITOMO PHARMACEUTICALS COMPANY, LIMITED (JP) 2001-08-08 EP disclosed